StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)

Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%

NeuroPace net income

Net income is the profit left for shareholders after every expense, interest and tax.

NeuroPace's net income for the twelve months ending Jun 30, 2026 was -$19.11M. For fiscal 2025 it was -$21.47M. The highest annual figure on record is -$21.47M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.47M–
FY2024Dec 31, 2024-$27.14M–
FY2023Dec 31, 2023-$32.96M–
FY2022Dec 31, 2022-$47.08M–
FY2021Dec 31, 2021-$36.08M–
FY2020Dec 31, 2020-$24.28M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.20M–
Q1 FY2026Mar 31, 2026-$6.69M–
Q4 FY2025Dec 31, 2025-$2.73M–
Q3 FY2025Sep 30, 2025-$3.50M–
Q2 FY2025Jun 30, 2025-$8.65M–
Q1 FY2025Mar 31, 2025-$6.59M–
Q4 FY2024Dec 31, 2024-$5.25M–
Q3 FY2024Sep 30, 2024-$5.45M–
Q2 FY2024Jun 30, 2024-$7.51M–
Q1 FY2024Mar 31, 2024-$8.93M–
Q4 FY2023Dec 31, 2023-$6.20M–
Q3 FY2023Sep 30, 2023-$7.26M–
Q2 FY2023Jun 30, 2023-$9.12M–
Q1 FY2023Mar 31, 2023-$10.38M–
Q4 FY2022Dec 31, 2022-$11.15M–
Q3 FY2022Sep 30, 2022-$11.79M–
Q2 FY2022Jun 30, 2022-$12.69M–
Q1 FY2022Mar 31, 2022-$11.46M–
Q4 FY2021Dec 31, 2021-$10.69M–
Q3 FY2021Sep 30, 2021-$8.08M–
Q2 FY2021Jun 30, 2021-$8.49M–
Q1 FY2021Mar 31, 2021-$8.81M–
Q4 FY2020Dec 31, 2020-$4.62M–
Q3 FY2020Sep 30, 2020-$4.13M–
Q2 FY2020Jun 30, 2020-$8.79M–
Q1 FY2020Mar 31, 2020-$6.74M–

More NeuroPace figures

See a number that looks wrong?